Literature DB >> 33844819

[Aseptic meningitis due to mumps vaccine. Case report and review of the literature].

Aline Jorquera L1, Daniela Ugarte C1, Carmen Avilés L1, Luis Delpiano M1.   

Abstract

We report the case of an older infant with no prior morbidity that approximately 3 weeks after receiving MMR vaccination (measles, mumps, rubella) was hospitalized for feverish symptoms, increased parotid volume and compromised consciousness. Aseptic meningitis was diagnosed, detecting pleocytosis in the CSF, predominantly mononuclear, and confirming by molecular biology, presence of parotid virus in CSF. A study was carried out by the Institute of Public Health of Chile, where serology (IgM and IgG) was positive. Saliva sample confirmed the etiology of parotid virus with genotype N. The evolution was favorable and at 6-month follow-up, there were no sequelae. Given this clinical situation, information regarding the association and causality of this clinical entity and the MMR vaccine, focused on different strains of the mumps virus, was reviewed.

Entities:  

Year:  2020        PMID: 33844819     DOI: 10.4067/S0716-10182020000600769

Source DB:  PubMed          Journal:  Rev Chilena Infectol        ISSN: 0716-1018            Impact factor:   0.520


  3 in total

1.  Aseptic Meningitis Following Second Dose of an mRNA Coronavirus Disease 2019 Vaccine in a Healthy Male: Case Report and Literature Review.

Authors:  Han Sol Kang; Ju Eun Kim; Jeong Rae Yoo; Hyunjoo Oh; Misun Kim; Young Ree Kim; Sang Taek Heo
Journal:  Infect Chemother       Date:  2022-01-27

Review 2.  Etiology, Clinical Phenotypes, Epidemiological Correlates, Laboratory Biomarkers and Diagnostic Challenges of Pediatric Viral Meningitis: Descriptive Review.

Authors:  Saleh M Al-Qahtani; Ayed A Shati; Youssef A Alqahtani; Abdelwahid Saeed Ali
Journal:  Front Pediatr       Date:  2022-06-16       Impact factor: 3.569

3.  Aseptic meningitis following AZD1222 COVID-19 vaccination.

Authors:  Arefeh Zavari; Negin Mahmoudi Hamidabad; Morteza Hassanzadeh
Journal:  Am J Emerg Med       Date:  2021-12-18       Impact factor: 4.093

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.